NetworkNewsBreaks – Earth Science Tech, Inc. (ET
Post# of 333
(Total Views: 234)
Posted On: 05/14/2018 4:57:01 PM
NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Positioned for Licensed Distribution of Products in Growing Canadian Marketplace
With a strong team in place, Earth Science Tech, Inc. (OTC: ETST) is well on its way to becoming a licensed distributor and bringing its products to the Canadian marketplace. Discussing the company’s strong team and positioning in the sector, ETST CEO and CSO Dr. Michel Aube stated in a news release, “We have all of the knowledge, experience and proficiency that we need to bring our products to the marketplace and become a licensed distributor of drugs and controlled substances in Canada, as announced earlier this year.” An article discussing the company reads: “The company has already received a grant through Canna Inno Laboratories Inc. from the Government of Québec to support the pre-launch process of three CBD-based products that aim to prevent common causes of cancer and help reduce occurrence rates. ETST is strategically working to improve treatments for different diseases on a global scale. Human clinical trials are set to begin in 2019, or later, in producing an over-the-counter (OTC) drug and a cannabinoid companion generic drug that battles opioid dependency. ETST is planning to investigate the synergies between mineral elements and cannabinoid industrial hemp oil. This could potentially be used as a treatment for opioid dependency.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
With a strong team in place, Earth Science Tech, Inc. (OTC: ETST) is well on its way to becoming a licensed distributor and bringing its products to the Canadian marketplace. Discussing the company’s strong team and positioning in the sector, ETST CEO and CSO Dr. Michel Aube stated in a news release, “We have all of the knowledge, experience and proficiency that we need to bring our products to the marketplace and become a licensed distributor of drugs and controlled substances in Canada, as announced earlier this year.” An article discussing the company reads: “The company has already received a grant through Canna Inno Laboratories Inc. from the Government of Québec to support the pre-launch process of three CBD-based products that aim to prevent common causes of cancer and help reduce occurrence rates. ETST is strategically working to improve treatments for different diseases on a global scale. Human clinical trials are set to begin in 2019, or later, in producing an over-the-counter (OTC) drug and a cannabinoid companion generic drug that battles opioid dependency. ETST is planning to investigate the synergies between mineral elements and cannabinoid industrial hemp oil. This could potentially be used as a treatment for opioid dependency.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)